Immunotherapy Overview: History of the Field

Yana Najjar, MD
University of Pittsburgh

Innate Immunity: Cellular Mechanisms and Signaling

Lewis Lanier, PhD
University of California San Francisco

Adaptive Immunity: Cellular Mechanisms and Signaling

Kristin Anderson, PhD University of Virginia 

Tumor Microenvironment: Complexity of Cells and Molecules Regulating Intratumoral Immunity

Victor Engelhard, PhD University of Virginia School of Medicine

Tumor Immunosuppression Mechanisms

Greg Delgoffe, PhD
University of Pittsburgh

TILs Presentation

Daniel Powell, PhD
University of Pennsylvania

Immunotherapeutic Strategy: Adoptive Cell and CAR T Therapies

Christian Capitini, MD
University of Wisconsin Madison

Immunotherapeutic Strategy: Immune Checkpoint Blockade

Sumit Subudhi, MD, PhD
The University of Texas MD Anderson Cancer Center

Breakout Session: Antigen Presentation
Peter Bruno, PhD
University of California San Francisco

Grantsmanship

Christian Capitini, MD
University of Wisconsin Madison

Presenting Your Data in Talks and Manuscripts

Melody Smith, MD, MS
Stanford University

B Cells and TLS

Tulia Bruno, PhD
 University of Pittsburgh

Synthetic Immunology: Harnessing the Tools of Synthetic Biology and Gene Editing to engineer Next-Generation Cell Therapies

Pre-Clinical Combination Immunotherapy

Gregory Lesinksi, PhD, MPH
Winship Cancer Institute at Emory University

Immunotherapeutic Strategy: Can Cancer Vaccines Really Work?

Olivera Finn, PhD
University of Pittsburgh

Off-the-Shelf Cell Products

May Daher, MD
The University of Texas MD Anderson Cancer Center

Combination Immunotherapies

Bambi Grilley, RPh
Baylor College of Medicine

Preclinical Assessment of Cell and Gene Therapy Products to Support IND

Yves Morillon, PhD
U.S. Food and Drug Administration

Patient Considerations that Impact Treatment and Clinical Trials and How to Work with Patient Representatives to Make Your Research More Successful

Deborah Collyar, BS
Patient Advocates in Research

Antigen Identification

James Heath, PhD
Institute for Systems Biology

Pre-Clinical Animal Models

Maryland Franklin, PhD
Labcorp

Autoimmunity and irAEs

Ryan Sullivan, MD
Harvard Medical School and Massachusetts General Hospital

Tumor Cell Analyses (Pathology)

Tricia Cottrell, MD, PhD
Queen's University

Applications of Computational Biology/Machine Learning to Immuno-Oncology

Robert Scharpf, PhD
Johns Hopkins University

Phase I Immunotherapy Clinical Trials

Chris Takimoto, MD, PhD
IGM Biosciences

Phase II and Phase III Immunotherapy Clinical Trials

Elizabeth Garrett-Mayer, PhD
American Society of Clinical Oncology

How to Get a Predictive Biomarker out of every Clinical Trial 

Gregory Lesinksi, PhD, MPH
Winship Cancer Institute at Emory University

Regulatory Issues Related to Cancer Immunotherapy 

Bambi Grilley, RPh
Baylor College of Medicine

Immunotherapy in Special Patient Populations

Ned Waller, MD, PhD
Emory University

Deep TCR and BCR Sequencing as a Biomarker for Cancer

Sacha Gnajtic, PhD
Icahn School of Medicine at Mount Sinai

Intratumoral and Local Therapy

Masataka Suzuki, PhD
Baylor College of Medicine

Development of a Grant/Translational Idea and Career Development Awards

Christian Capitini, MD 
University of Wisconsin-Madison

Sumit Subudhi, MD, PhD
The University of Texas MD Anderson Cancer Center

Careers in Cancer Immunotherapy Panel Discussion

Paola Grandi, PhD
CG Oncology

Chrystal Paulos, PhD
Winship Cancer Institute at Emory University

Marc Theoret, MD, PhD
US Food and Drug

Perspective on Direction of the Field

Christian Capitini, MD
University of Wisconsin-Madison

Closing Remarks